Su proyecto investiga la aplicación de inmunoterapia celular adoptiva con Car-T para la leucemia linfoblástica aguda T cortical, evaluando la eficacia de una terapia que se dirige contra una nueva diana segura y sin apenas presencia en tejidos sanos. One Chain Immunotherapeutics 👉

🔬Asociación Española Contra el Cáncer is leading efforts to convert research into solutions that enhance patients' quality of life.

At #OneChain , we're proud to be part of this ecosystem by developing a #CARTtherapy for an aggressive leukemia subtype, thanks to AECC IMPACT grant.

🌟 Exciting news at #OneChain ! We warmly welcome Irene, a recent PhD in Cancer Immunotherapy from CIMA. Her innovative research will enhance our team's efforts in #CancerResearch . 💪

Welcome, Irene! Learn more about her and our team here: onechaintx.com/team

📻 Proud to share our research director participation in
La Brújula, talking about the TransMisiones project.
🧬This cutting-edge initiative harnesses #AI to design viral particles for advanced therapies like #CARTs .

Listen from minute 1:20:00 👇ondacero.es/emisoras/catal…

👨‍💻 Yesterday, we celebrated the 1st anniversary of our EIC Transition Project by meeting with our partners.
During the session, we had the opportunity to discuss the progress made so far and plan our work for the coming months 👣

📢 Exciting opportunity at OneChain !

We're looking for a Research Assistant specialized in iPSC to join our team! Competitive salary, collaborative environment, and a mission to combat cancer.

Apply by 06/05/2024! Details ➡️ linkedin.com/feed/update/ur…

🌟 Exciting times at the AdTherapiesCongress in London!

Our CEO chaired the Engineered Cell Therapies track & discussed Autologous vs Allogeneic therapies. A pivotal event for #CellTherapy & #GeneTherapy innovation. Proud to represent our vision globally!

🌟 Big win for #OneChain ! Awarded a €450K grant to develop a CAR T therapy for a rare leukemia type with no current treatments. Thanks to the Asociación Española Contra el Cáncer for supporting our research.

Together, we're making strides in cancer fight! #Innovation #FightingCancer

✨ #Innovation success at IJC!

The spin-off One Chain Immunotherapeutics receives support from Ministerio de Ciencia, Innovación y Universidades to advance a promising CAR-T technology-based therapy for acute lymphoblastic leukaemia type T into clinical phase.

Read the full article here ⬇️
carrerasresearch.org/en/news/onecha…

🎉 Groundbreaking discovery in multiple myeloma treatment!
A team led by Hospital Clínic-IDIBAPS unveils the first model to predict #CARTcell therapy success, identifying key biomarkers for personalized care #Innovation #Healthcare

More info 👇clinicbarcelona.org/en/news/presen…

This weekend, our founder Pablo Menéndez (Menendez Lab) attended the 6th European CAR T Cell Meeting held in Valencia!
💡 An unbeatable opportunity to deepen in CAR T innovations with the best experts. Thank you very much for this enriching experience! European Hematology Association The EBMT

📣 The Josep Carreras Leukaemia Research Institute (IJC) is still looking for 14 excellent candidates to join the CarrerasPathfinders doctoral program!!

📅Apply before March 1st!

💛 This #ChildhoodCancer Day, OneChain joins the global call for #EarlyDetection in childhood cancers. Our work, especially against pediatric #leukemia & collaboration with Hospital Sant Joan de Déu Barcelona ES with the #CARxALL trial, underscores our dedication to ifight these diseases #ICCD2024 .

🌟 Excited to be featured in the 2023 BioRegion Report by Biocat! As a leading CAR-T innovator in Catalonia, we're part of this dynamic ecosystem with 1,400 companies & 91 research entities driving progress in #lifesciences 🚀

📖 Full report here report.biocat.cat

👩‍🔬 Celebrating #WomenInScience Day! At #OneChain , we honor women's vital contributions to science and celebrate the innovations driven by the women on our team.

✨ Scientific progress needs diverse perspectives, let's build a healthier, equitable future together! #February11

🟥 February #BioRegionJobs 🔝 offers:

🔹Director (Institut d'Investigació i Innovació Parc Taulí)
🔹Clinical Research Associate (@ISGLOBALorg)
🔹Lab Technician (@onechaintx)
🔹Bioinformatician (@peptomyc)
🔹Research Engineer (@BSC_CNS)
🔹Research Technician in Neuroscience (@UABBarcelona)

➕ tuit.cat/0jt2T